Developing a Booster Session for Problem Management Plus in the Bahamas: A Pilot Randomized Controlled Trial
Development, Feasibility, and Acceptability of a One-time Problem Management Plus (PM+) Booster Session in the Bahamas: A Pilot Randomized Controlled Trial
1 other identifier
interventional
50
1 country
1
Brief Summary
Therapists at the Grand Bahama Resilience Center (GBRC) will be trained to deliver Problem Management Plus (PM+), a WHO intervention. Then, those therapists will deliver PM+ (5 one-on-one skills-based sessions) to a total of 50 adult clients experiencing mild to moderate mental health difficulties (excluding anyone with cognitive difficulties or psychosis). Participants will complete (de-identified) self-report survey assessments before PM+, after PM+, 3 months later, and 6 months later. After receiving 5 sessions of PM+, participants will be randomized to either receive a one-time booster session of PM+ (to be co-created by the PI and the GBRC providers) three months later or to a control group which will receive a phone call reminding them that they will receive their third assessment soon.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 16, 2024
CompletedFirst Submitted
Initial submission to the registry
September 27, 2025
CompletedFirst Posted
Study publicly available on registry
October 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
January 6, 2026
September 1, 2025
1.8 years
September 27, 2025
January 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hospital Anxiety and Depression Scale
Hospital Anxiety and Depression Scale (HADS) (Zigmond \& Snaith, 1983) is a 14-item scale, which consists of two subscales of seven items each. One subscale measures symptoms of anxiety (HADS-A) and the other measures symptoms of depression (HADS-D). Responses are reported a four-point Likert scale, from 0-3, which pertain to different levels of symptom severity, depending on the question. Responses are summed to produce a total score, where higher scores indicate greater levels of anxiety and depression. Subscale scores may also be totaled to separate depression and anxiety symptoms. This scale has been used widely throughout the world and across many cultures, including in the US and in South America (Herrmann, 1997).
From enrollment, again at week5, again at week 18 and finally at week 30
Secondary Outcomes (8)
PHQ-9
At enrollment, again at week 5, again at week 18, and finally at week 30
GAD-7
At enrollment, again at week 5, again at week 18, and finally at week 30
PSYCHLOPS
At enrollment, at week 1, 2, 3, 4, and 18
PCL-5
At enrollment, again at week 5, again at week 18, and finally at week 30
WHODAS-2.0
At enrollment, again at week 5, again at week 18, and finally at week 30
- +3 more secondary outcomes
Study Arms (2)
Booster Session Arm
EXPERIMENTALThis group will receive a one-time PM+ booster session three months after finishing the PM+ program
Control
NO INTERVENTIONThis group will receive the full PM+ program but no booster session or meeting thereafter.
Interventions
A 60-minute session designed to refresh participants on the PM+ strategies (diaphragmatic breathing, problem management, behavioral activation, strengthening social support). Session consists of practicing strategies and developing plans for the future.
Eligibility Criteria
You may qualify if:
- Adults of 18 years or above
- English-speaking
- A score of \<91 on Global Assessment of Functioning
- Located in the Bahamas
You may not qualify if:
- ● Imminent suicide risk (assessed at screening using Columbia Suicide-Severity Rating Scale, see document titled " Screener updated 10-30- 24")
- Severe mental disorder (e.g. psychotic disorders)
- Severe cognitive impairment (e.g. severe intellectual disability or dementia)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The New Schoollead
Study Sites (1)
Grand Bahama Resilience Center
Freeport, Grand Bahama, The Bahamas
Related Publications (3)
Rahman A, Hamdani SU, Awan NR, Bryant RA, Dawson KS, Khan MF, Azeemi MM, Akhtar P, Nazir H, Chiumento A, Sijbrandij M, Wang D, Farooq S, van Ommeren M. Effect of a Multicomponent Behavioral Intervention in Adults Impaired by Psychological Distress in a Conflict-Affected Area of Pakistan: A Randomized Clinical Trial. JAMA. 2016 Dec 27;316(24):2609-2617. doi: 10.1001/jama.2016.17165.
PMID: 27837602BACKGROUNDDawson KS, Bryant RA, Harper M, Kuowei Tay A, Rahman A, Schafer A, van Ommeren M. Problem Management Plus (PM+): a WHO transdiagnostic psychological intervention for common mental health problems. World Psychiatry. 2015 Oct;14(3):354-7. doi: 10.1002/wps.20255. No abstract available.
PMID: 26407793BACKGROUNDBryant RA, Schafer A, Dawson KS, Anjuri D, Mulili C, Ndogoni L, Koyiet P, Sijbrandij M, Ulate J, Harper Shehadeh M, Hadzi-Pavlovic D, van Ommeren M. Effectiveness of a brief behavioural intervention on psychological distress among women with a history of gender-based violence in urban Kenya: A randomised clinical trial. PLoS Med. 2017 Aug 15;14(8):e1002371. doi: 10.1371/journal.pmed.1002371. eCollection 2017 Aug.
PMID: 28809935BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Adam Brown D Brown, PhD
The New School
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Because the intervention and control groups involve receiving or not receiving a booster session, neither participants nor providers can be blinded. Because the administration and data collection is being completed by the PI, who is also responsible for study administration, the PI cannot be blinded. Instead, randomization occurs after delivery of PM+ to avoid bias in PM+ delivery, and contact between the study administrator is limited to emailing questionnaires (with standardized language that does not differ between groups).
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Candidate, Clinical Psychology
Study Record Dates
First Submitted
September 27, 2025
First Posted
October 6, 2025
Study Start
October 16, 2024
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
January 6, 2026
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share